论文部分内容阅读
目的:分析在临床患有胃溃疡患者的治疗中,将胃达喜分别与奥美拉唑及埃索美拉唑联合应用的治疗效果。方法:选择我院于2015年8月至2016年10月期间收治的56例胃溃疡患者为对象,将其随机均分作常规组与干预组,两组患者均服用胃达喜,常规组在此基础上联合服用奥美拉唑,干预组则在服用胃达喜基础上联合服用埃索美拉唑,对比两组患者的临床治疗效果。结果:干预组患者的具体治疗效果明显好于常规组,两组患者的数据接受比对后存在明显的差异(P<0.05)。结论:在临床胃溃疡患者的具体治疗中,将胃达喜与埃索美拉唑联合应用的效果较好,值得推广。
OBJECTIVE: To analyze the therapeutic effect of Weidaixi in combination with omeprazole and esomeprazole in the treatment of patients with clinical gastric ulcer. Methods: Fifty-six patients with gastric ulcer admitted from August 2015 to October 2016 in our hospital were randomly divided into routine group and intervention group. Both groups were treated with Weidaqi, On this basis, omeprazole was taken in combination with the intervention group, esomeprazole was taken on the basis of taking daegen, and the clinical effect of the two groups was compared. Results: The specific treatment effect of the intervention group was significantly better than that of the conventional group. There was a significant difference (P <0.05) between the two groups after receiving the data. Conclusion: In the specific treatment of patients with clinical gastric ulcer, the combination of weidaixi and esomeprazole is effective and worth promoting.